Share
Title
Code
Session Type
Track
Channel
Date Time
Local Date Time
Moderator:

COVID-19 and HIV offer many opportunities for both responses to learn from each other. Drawing on lessons from a global response to COVID-19 and forty years of experience with HIV, this session will explore the latest developments on monoclonal antibodies and how they can influence the prevention and treatment of both HIV and COVID-19.

2 min
Introduction
Sharon LEWIN, University of Melbourne, Australia
10 min
What we learned from HIV, What we did for SARS-CoV2
Marina CASKEY, The Rockefeller University, United States
Slides
10 min
Neutralizing monoclonal antibodies against SARS-CoV-2 and use for vaccine design
Penny MOORE, University of the Witwatersrand, South Africa
PDF
10 min
bnAbs for the prevention of infectious diseases dream or reality
Ayesha SITLANI, International AIDS Vaccine Initiative (IAVI), United States
PDF
18 min
Live Q&A
Penny MOORE, University of the Witwatersrand, South Africa
Marina CASKEY, The Rockefeller University, United States
Ayesha SITLANI, International AIDS Vaccine Initiative (IAVI), United States
Sharon LEWIN, University of Melbourne, Australia
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT